Financial News Feed

Weaker Buy Today XLRN ranks #1457 as BUY CANDIDATE. Stronger Buy
Today XLRN ranks #1457 as BUY CANDIDATE.

XLRN stock Acceleron Pharma Inc.

XLRN stock
Acceleron Pharma Inc.

United Technologies Corp (UTX) investors sentiment increased to 1.26 in 2018 Q4. It’s up 0.17, from 1.09 in 2018Q3. The ratio has improved, as 692 institutional investors increased or opened new hol...

Read more

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Tullow Oil plc LSE:TLW is 1.517915. A lower price to book ratio indicat...

Read more

As Biotechnology businesses, Apellis Pharmaceuticals Inc. (NASDAQ:APLS) and Acceleron Pharma Inc. (NASDAQ:XLRN), are affected by compare. This especially...

Read more

As Biotechnology companies, PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS) and Acceleron Pharma Inc. (NASDAQ:XLRN) are our subject to compare. And more...

Read more

Both Innovate Biopharmaceuticals Inc. (NASDAQ:INNT) and Acceleron Pharma Inc. (NASDAQ:XLRN) are each other’s competitor in the Biotechnology industry. Thus the...

Read more

ProQR Therapeutics N.V. (NASDAQ:PRQR) and Acceleron Pharma Inc. (NASDAQ:XLRN) compete against each other in the Biotechnology sector. We will contrast them and contrast their institutional ownership, ...

Read more

Tracking recent action on shares of Acceleron Pharma Inc. (NASDAQ:XLRN) we have noted that the stock price has been spotted trading around $45.23. Investors may be closely following price activity on ...

Read more

Major market players are buzzing over Acceleron Pharma Inc. (NASDAQ:XLRN) as their share price hit $45.23 at the end of the most recent trading session. Outstanding shares are common stock authorized ...

Read more

Unum Therapeutics Inc. (NASDAQ:UMRX) and Acceleron Pharma Inc. (NASDAQ:XLRN), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the ...

Read more

This is therefore a contrasting of the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation in Stemline Therapeutics Inc. (NASDAQ:STML) and Accelero...

Read more

This is a contrast between Arcus Biosciences Inc. (NYSE:RCUS) and Acceleron Pharma Inc. (NASDAQ:XLRN) based on their profitability, analyst recommendations,...

Read more

The Piotroski F-Score of Tullow Oil plc (LSE:TLW) is 7. The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s ...

Read more

Brokerages forecast that Acceleron Pharma Inc (NASDAQ:XLRN) will post sales of $3.79 million for the current quarter, Zacks reports. Three analysts have provided estimates for Acceleron Pharma’s ear...

Read more

Big Money Sentiment increased to 1.11 in 2018 Q4. It has change of 0.08, from 2018Q3's 1.03. The ratio increased due to Acceleron Pharma Inc. positioning: 19...

Read more

The EBITDA Yield is a great way to determine a company’s profitability. This number is calculated by dividing a company’s earnings before interest, taxes, depreciation and amortization by the comp...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank